Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Hypertension (Dallas, Tex. : 1979)|February 4, 2020
Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation ConsortiumKazuomi Kario, Byeong-Keuk Kim, Jiro Aoki, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 27, 2004
Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot studyAaron Wong, Koon-Hou Mak, Charles Chan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 27, 2019
Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion ClubEugene B Wu, Emmanouil S Brilakis, Sidney Lo, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2020
Clinical Updates on the Diagnosis and Management of Chronic Thromboembolic Pulmonary HypertensionWen Ruan, Jonathan Jl Yap, Kevin Kh Quah, et al.
Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
JACC. Asia|February 19, 2025
New Frontiers in Antegrade Wiring From the Asia Pacific Chronic Total Occlusion ClubEugene B Wu, Shunsuke Matsuno, Wataru Nagamatsu, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent StudyJohn A Ormiston, Ehtisham Mahmud, Mark A Turco, et al.
Lancet (London, England)|October 17, 2015
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 8, 2021
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 YearsMichael Haude, Ralph Toelg, Pedro Alves Lemos, et al.
Pageof 7